Current pharmacological treatments for bronchiolitis are useless. The case for the con's.

Bronchiolitis is a recognized syndrome seen in infants following viral infections. The pattern is different in different countries related to the socio-economic conditions. A sequel that needs to be addressed is post-viral wheeze. Oxygen is the major beneficial pharmacological agent. Bronchodilators may be effective in some. There is a role for Palivizumab and Montelukast in selected infants. It is essential to define the right drug for the right patient at the right dose and the right time.